The discovery of genotype 16 as the prototype oncogenic human papillomavirus (HPV)
initiated a quarter century of laboratory and epidemiological studies that demonstrated their …

Human papillomavirus (HPV) infection represents a significant global health concern owing
to its role in the etiology of conditions ranging from benign low-grade lesions to cancers of …

Human papillomavirus (HPV) is causally associated with 5% of cancers, including cancers
of the cervix, penis, vulva, vagina, anus and oropharynx. The most carcinogenic HPV is HPV …

A subset of human papillomavirus (HPV) genotypes is responsible for∼ 5% of all cancer
deaths globally, and uterine cervical carcinoma accounts for the majority of these cases. The …

High-risk types of human papillomavirus (HPV) cause over 500,000 cervical, anogenital and
oropharyngeal cancer cases per year. The transforming potential of HPVs is mediated by …

Globally, human papillomavirus (HPV) infection is one of the most common sexually
transmitted infection. HPV is linked to at least five malignancies including vulvar, vaginal …

Cervical and other anogenital cancers are initiated by infection with one of a small group of
human papillomaviruses (HPV). Virus-like particle-based vaccines have recently been …

A subset of human papillomaviruses (HPVs) promote anogenital malignancy, including
cervical cancer, and prevention and treatment strategies that reflect the causal role of HPV …

Human papillomavirus (HPV) is the most common sexually transmitted infectious agent; its
14 oncogenic types are causally associated with 5–10% of all cancers. The major structural …

Introduction: Identification of human papillomavirus (HPV) as the etiologic factor of cervical,
anogenital, and a subset of head and neck cancers has stimulated the development of …